Nicotine Patch Trial in Syrian Primary Care Settings

PHASE2CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Smoking Cessation
Interventions
DRUG

Transdermal Nicotine

Subjects in the experimental group receive six weeks of nicotine patch treatment, 24 hour dose, using a step-down algorithm. Participants who smoke greater than 10 cigarettes/day receive two weeks of 21 mg patch, followed by two weeks of 14 mg patch, and then two weeks of 7 mg patch. Participants who smoke 5-9 cigarettes per day receive four weeks of 14 mg patch, followed by two weeks of 7 mg.

DRUG

Placebo nicotine patch

"Subjects in the placebo condition receive an inert placebo patch matched for size, shape, color, and packaging.~The same step-down dosing algorithm as in the experimental condition is used."

Trial Locations (1)

Unknown

Four privately- or NGO-sponsored adult primary care clinics, Aleppo

All Listed Sponsors
lead

University of Memphis

OTHER

NCT01085032 - Nicotine Patch Trial in Syrian Primary Care Settings | Biotech Hunter | Biotech Hunter